Lung function decline in asthma and early intervention with inhaled corticosteroids

Chest

Volumn 129, Issue 6, 2006, Pages 1405-1406

  Haahtela, Tari ^a,b  

^a Helsinki University Central Hospital ^*

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID;

ASTHMA; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFICACY; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG FUNCTION; PRIORITY JOURNAL; THERAPY DELAY;

EID: 33745119438     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.6.1405     Document Type: Editorial

References (18)

1. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide in newly detected asthma. N Engl J Med 1991; 325:388-392
2. Haahtela T, Tuomisto LE, Pietinalho A, et al. A ten-year asthma programme in Finland: change for the better. Thorax (in press)
3. Agency for Healthcare Research and Quality. Effects of delayed ICS on progression and reversibility. In: Management of chronic asthma. Rockville, MD: AHRQ, 2001; Publication No. 01-E-044
4. Boushey H. Daily inhaled corticosteroid treatment should not be prescribed for mild persistent asthma. Am J Respir Crit Care Med 2005; 172:412-414
5. O'Byrne P. Daily inhaled corticosteroid treatment should be prescribed for mild persistent asthma. Am J Respir Crit Care Med 2005; 172:410-412
6. Ernst P. Inhaled corticosteroids moderate lung function decline in adults with asthma. Thorax 2006; 61:93-94
7. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339:1194-1200
8. Boushey HA, Sorkness CA, King TS, et al. Daily versus as needed corticosteroids for mild persistent asthma. N Engl J Med 2005; 352:1519-1528
9. O'Byrne P, Pedersen S, Busse WW, et al. Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest 2006; 129:1478-1485
10. Pauwels RA, Pedersen S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 2003; 361:1071-1076
11. Jones C, Santanello NC, Boccuzzi SJ, et al. Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data. J Asthma 2003; 40:93-101
12. Rytilä P, Metso T, Heikkinen K, et al. Airway inflammation in patients with symptoms suggesting asthma but with normal lung function. Eur Respir J 2000; 16:824-830
13. Smith AD, Cowan JO, Brasset KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352:2163-2173
14. Lange P, Scharling H, Ulrik CS, et al. Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 2006; 61:100-104
15. Haahtela T, Järvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331:700-705
16. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in children. Respir Med 1994; 88:373-381
17. Selroos O, Pietinalho A, Löfroos AB, et al. Effect of early vs. late intervention with inhaled corticosteroid in asthma. Chest 1995; 108:1228-1234
18. Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343:1054-1063